June 15, 2009
Schering-Plough Corporation
2000 Galloping Hill Road
Kenilworth, NJ 07033
Re: Registration Statement on Form S-4
Ladies and Gentlemen:
This opinion is furnished to you in connection with a registration statement on Form S-4
(Registration No. 333-159371) (the Registration Statement) filed with the Securities and
Exchange Commission under the Securities Act of 1933, as amended (the Securities Act) for
the registration of the shares of common stock, $0.50 par value (the Shares), of
Schering-Plough Corporation, a New Jersey corporation (SPC), which shares are expected to
be issued to shareholders of SPC and shareholders of Merck & Co., Inc., a New Jersey
corporation (Merck), pursuant to the Agreement and Plan of Merger dated March 8, 2009, by
and among SPC; Merck; SP Merger Subsidiary One, Inc., a New Jersey corporation and
wholly-owned subsidiary of SPC formerly known as Blue, Inc.; and SP Merger Subsidiary Two,
Inc., a New Jersey corporation and wholly-owned subsidiary of SPC formerly known as Purple,
Inc. (the Merger Agreement).
We have acted as special New Jersey counsel to SPC in connection with the Merger
Agreement and the proposed issuance of the Shares included in the Registration Statement. We
have examined such corporate records, certificates and other documents, and such questions of
law, as we have considered necessary to render this opinion. We have relied as to certain
matters on information obtained from public officials, officers of SPC and other sources
believed by us to be responsible, and we have assumed that the Merger Agreement has been duly
authorized, executed and delivered by Merck and is a legal, valid and binding obligation of
the parties thereto, and that the signatures on all documents examined by us are genuine,
assumptions which we have not independently verified.
In rendering this opinion, we have assumed that prior to the issuance of any Shares:
1. the Registration Statement, as then amended, will have become effective under the
Securities Act;
2. the shareholders of each of SPC and Merck will have approved each of the proposals to
approve the Merger Agreement which are to be presented and voted upon at their respective
meetings as set forth in the joint proxy statement/prospectus included in the
Registration Statement, including, in the case of SPC, the issuance of the Shares and
the adoption of the Restated Certificate of